NCT07134881

Brief Summary

The goal of this two-armed, parallel-design, pre-/post-intervention assessment clinical trial is to learn if a digital and interactive website helps to improve advance care planning (ACP) engagement among caregivers of patients with serious illness. The main questions it aims to answer are: Does the website increase ACP engagement of caregivers of patients with serious illness? Researchers will compare the digital and interactive website to the usual care (a digital booklet) to see if the digital intervention works to improve ACP engagement among caregivers. Participants who are caregivers will:

  • Be introduced to a digital website and asked to explore the site over the course of the study.
  • Complete four self-administered questionnaires (baseline, one-week, six-week, and six-month). Participants who are patients will not have any intervention assigned and will only have their observational data collected through four interviewer-administered questionnaires (baseline, one-week, six-week, and six-month)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
15mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Aug 2025Jul 2027

First Submitted

Initial submission to the registry

August 14, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

August 27, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

August 14, 2025

Last Update Submit

September 12, 2025

Conditions

Keywords

randomised control trialdigital interventionadvance care planninggoals of carepalliative care

Outcome Measures

Primary Outcomes (1)

  • Advance Care Planning Engagement Survey for Surrogate Decision-Maker

    The 17-item ACP Surrogate Decision Making Instrument (ACP-17 SDM) developed by Sudore et. al., is a validated questionnaire designed to assess how engaged surrogate decision makers (SDMs) are in the advance care planning process. The ACP-17 SDM measures engagement across three domains: 1) Serving as SDM (7 items), 2) Contemplation (4 items), and 3) Readiness (6 items). Each item is answered on a 5-point Likert scale (1 = not at all/never, to 5 = extremely/A lot), and higher mean scores (range: 1.0 - 5.0) indicate higher engagement in ACP by the surrogate. Van Scoy, Lauren J., et al. "Adaptation and preliminary validation of the advance care planning engagement survey for surrogate decision makers." Journal of pain and symptom management 57.5 (2019): 980-988.

    Baseline, 1-week, and 6-week

Secondary Outcomes (8)

  • Satisfaction with care

    Baseline, 6-week, and 6-month

  • Satisfaction with care - Feeling Heard and Understood

    Baseline, 6-week, and 6-month

  • Goals of care

    Baseline, 1-week, 6-week, and 6-month

  • Caregivers Wellbeing

    Baseline, 1-week, 6-week, and 6-month

  • Caregiver quality of life - Mental health

    Baseline, 1-week, 6-week, and 6-month

  • +3 more secondary outcomes

Study Arms (2)

Comparator arm

ACTIVE COMPARATOR

For caregiver participants: Usual care. For patient participants: usual care, as prescribed by the clinical care team, is unaffected by the study design and we only conduct observational measurements of patient participants during the course of the study.

Other: Usual Care

Intervention arm

EXPERIMENTAL

For caregiver participants: Enrolled caregiver participants randomised in the intervention arm will be directed to the intervention digital website and guided through the signup process. Once logged in, they are asked to explore and use the website contents and tools in their own time. For patient participants: usual care, as prescribed by the clinical care team, is unaffected by the study design and we only conduct observational measurements of patient participants during the course of the study.

Behavioral: Careverse

Interventions

CareverseBEHAVIORAL

Careverse is a digital psychoeducational website designed to assist caregivers and patients to clarify their values, end-of-life preferences, enable surrogates to further their understanding of the patient's wishes, and prepare surrogates for the role and responsibilities of a medical decision maker. The intervention consists of values elicitation tools, educational materials, and testimonies. The participants will receive guides on how to initiate/re-introduce discussions about end-of-life wishes with their loved ones and clinicians.

Intervention arm

Caregivers in the comparator arm will receive a digital version of standard advanced care planning education material prepared by Agency of Integrated Care. The ACP Workbook is created by AIC to help individuals explore their values, care preferences, and end-of-life goals in a structured, reflective way.

Comparator arm

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Singapore resident aged 21years and above,
  • patient able to identify one main caregiver in the care and medical decision-making for the patient;
  • patient able to communicate in either English, Chinese, Malay or Tamil;
  • patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or brain metastases.
  • b. Patients with spontaneous intracerebral haemorrhage (SICH) based on radiological diagnosis of SICH on baseline computed-tomographic scans.
  • c. Patients with CKD Stage 4 and 5, identified at G4 or G5 of CKD, glomerular filtration rate (GFR) 30 ml/min or less, inclusive of kidney failure on kidney replacement therapy; and (5) Physicians assessment that ACP is appropriate for the patient by physicians.\* (\*) The attending clinicians may base the assessment of ACP appropriateness on several factors in addition to high mortality risk. As a baseline, clinicians are asked to base their assessment of high mortality risk using the validated "Surprise" question.

You may not qualify if:

  • Patients unable to identify a caregiver who is a medical decision-maker,
  • Patients are currently or was previously healthcare workers; or
  • Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test.
  • caregivers are identified as a medical decision-maker for the patient
  • Singapore resident aged 21 years and above; and
  • able to communicate in English
  • caregivers are currently or were previously healthcare workers;
  • caregivers not involved in primary care of the patient (including providing care to the patient, supervision of care, or involved in making decisions regarding treatment the patient receives); or
  • caregivers diagnosed with dementia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital

Singapore, 119074, Singapore

RECRUITING

Study Officials

  • Gerald Choon Huat Koh, PhD(FM)

    Saw Swee Hock School of Public Health, National University of Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Treatment allocation will be masked from participants for the entirety of the study. We do not anticipate unblinding of participants to treatment status. Effort to maintain blinding of participants include training our research coordinators (RCs) to strictly follow a protocol and script in all interactions with participants. RCs are blinded of treatment allocation during recruitment, consent-taking and baseline survey process, minimising the risk of selection bias. Once participants are randomised into their allocated arm, RCs will be aware of the participant's treatment allocation as RCs will need to ensure that participants successfully complete the signup process required for the intervention arm. Risks of unmasking caregivers participants is minimal as followup questionnaires are completed via self-administered online survey without the RCs being present.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This study is a single-blind, participant-level randomised trial. Upon providing consent and completion of the baseline survey, enrolled caregiver participants will be randomly assigned 1:1 to the experimental and comparator arms using the built-in randomizer function in the online survey software (Qualtrics). Balance between the allocation arms will be achieved by stratifying based on illness.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 14, 2025

First Posted

August 21, 2025

Study Start

August 27, 2025

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

September 15, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The study gathers sensitive medical and personal data from patients and caregivers that cannot be disclosed publicly.

Locations